CYCLERION THERAPEUTICS, INC. Loss Contingency Accrual
CYCLERION THERAPEUTICS, INC. (CYCN) had Loss Contingency Accrual of $0 as of 2025-12-31, per its S-4/A filed 2026-07-22.
Financial Statements › Notes
us-gaap:LossContingencyAccrualAtCarryingValue · last filed 2026-07-22
- 2025-12-31: Loss Contingency Accrual $0.00.
- 2024-12-31: Loss Contingency Accrual $0.00.
- 2023-12-31: Loss Contingency Accrual $0.00.
| Period end | Loss Contingency Accrual |
|---|---|
| 2025-12-31 | $0.00 S-4/A · filed 2026-07-22 |
| 2024-12-31 | $0.00 S-4/A · filed 2026-07-22 |
| 2023-12-31 | $0.00 10-K/A · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |